Clinical Trial Update: Long-term Data Collection for Subjects in MDX-010 Studies

View source ↗

Summary

An update indicating ongoing long-term data collection for subjects enrolled in MDX-010 studies (ipilimumab) for metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Metastatic Melanoma | Status: COMPLETED